Buclizine
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| (RS)-1-[(4-chlorophenyl)- phenyl-methyl]-4- [(4-tert-butylphenyl) methyl] piperazine | |
| Clinical data | |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 82-95-1 |
| ATC code | R06AE01 |
| PubChem | CID 6729 |
| DrugBank | APRD00723 |
| ChemSpider | 6473 |
| UNII | 0C94V6X681 |
| ChEBI | CHEBI:3205 |
| ChEMBL | CHEMBL1201271 |
| Chemical data | |
| Formula | C28H33ClN2 |
| Mol. mass | 433.028 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
Buclizine is an antihistamine and anticholinergic of the piperazine derivative family. It is considered to be an antiemetic, similar to meclozine.
In the United Kingdom, buclizine is one of three drugs contained in Migraleve tablets, marketed by McNeil Healthcare at migraine sufferers.
[edit] See also
[edit] References
|
|
| This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |

